Should AstraZeneca Stock Be in Your Portfolio Pre-Q4 Earnings?

AstraZeneca (AZN) will report its fourth-quarter and full-year 2024 earnings on Feb. 6, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $14.28 billion and$1.06 per share, respectively. Earnings estimates for AstraZeneca have declined from $4.69 per share to$4.66 per share for 2025 over the past 30 days.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.AZN Estimate Movement Image Source: Zacks Investment ResearchEarnings Surprise History for AZNThe ...